These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test. Nic Dhonnchadha BA, Ripoll N, Clénet F, Hascoët M, Bourin M. Psychopharmacology (Berl); 2005 May; 179(2):418-29. PubMed ID: 15821956 [Abstract] [Full Text] [Related]
7. Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice. Ripoll N, Hascoët M, Bourin M. Behav Brain Res; 2006 Jan 06; 166(1):131-9. PubMed ID: 16154212 [Abstract] [Full Text] [Related]
8. Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the four-plate test in Swiss mice. Bourin M, Hascoët M. Behav Brain Res; 2010 Apr 02; 208(2):352-8. PubMed ID: 20006646 [Abstract] [Full Text] [Related]
9. Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism. Nakamura K, Kurasawa M. Eur J Pharmacol; 2001 May 18; 420(1):33-43. PubMed ID: 11412837 [Abstract] [Full Text] [Related]
10. Alpha-adrenoceptor-mediated modulation of 5-HT2 receptor agonist induced impulsive responding in a 5-choice serial reaction time task. Koskinen T, Haapalinna A, Sirviö J. Pharmacol Toxicol; 2003 May 18; 92(5):214-25. PubMed ID: 12753409 [Abstract] [Full Text] [Related]
11. A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety. Griebel G, Perrault G, Sanger DJ. Neuropharmacology; 1997 Jun 18; 36(6):793-802. PubMed ID: 9225307 [Abstract] [Full Text] [Related]
12. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated. Kennett GA, Trail B, Bright F. Neuropharmacology; 1998 Dec 18; 37(12):1603-10. PubMed ID: 9886683 [Abstract] [Full Text] [Related]
13. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes. Song J, Hanniford D, Doucette C, Graham E, Poole MF, Ting A, Sherf B, Harrington J, Brunden K, Stricker-Krongrad A. Assay Drug Dev Technol; 2005 Dec 18; 3(6):649-59. PubMed ID: 16438660 [Abstract] [Full Text] [Related]
14. SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP. Neuropharmacology; 1997 Dec 18; 36(4-5):609-20. PubMed ID: 9225286 [Abstract] [Full Text] [Related]
15. Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors. Chaouloff F, Kulikov A, Mormède P. Eur J Pharmacol; 1997 Sep 03; 334(1):25-9. PubMed ID: 9346323 [Abstract] [Full Text] [Related]
16. Role of 5-HT2A and 5-HT2C receptor subtypes in the two types of fear generated by the elevated T-maze. Mora PO, Netto CF, Graeff FG. Pharmacol Biochem Behav; 1997 Dec 03; 58(4):1051-7. PubMed ID: 9408213 [Abstract] [Full Text] [Related]
17. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice. Gomes KS, Nunes-De-Souza RL. Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct 01; 33(7):1261-9. PubMed ID: 19625008 [Abstract] [Full Text] [Related]
18. Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action. Bourin M, Masse F, Dailly E, Hascoët M. Pharmacol Biochem Behav; 2005 Jul 01; 81(3):645-56. PubMed ID: 15961146 [Abstract] [Full Text] [Related]
19. 5-HT2C receptor involvement in female rat lordosis behavior. Wolf A, Caldarola-Pastuszka M, DeLashaw M, Uphouse L. Brain Res; 1999 Apr 17; 825(1-2):146-51. PubMed ID: 10216181 [Abstract] [Full Text] [Related]
20. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents. Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan MJ. Psychopharmacology (Berl); 2000 Sep 17; 152(1):55-66. PubMed ID: 11041316 [Abstract] [Full Text] [Related] Page: [Next] [New Search]